EPISODE · Dec 13, 2024 · 18 MIN
Srikala Sridhar, MD, MSc, FRCPC - Transforming Care With Immunotherapy Combinations in the First-Line Treatment of Advanced or Metastatic Urothelial Carcinoma
from PeerVoice Clinical Pharmacology Video · host PeerVoice
Srikala Sridhar, MD, MSc, FRCPC - Transforming Care With Immunotherapy Combinations in the First-Line Treatment of Advanced or Metastatic Urothelial Carcinoma
Embed this episode
What this episode covers
Visit https://www.peervoice.com/TBT860 to view the entire programme with slides. After completing “Srikala Sridhar, MD, MSc, FRCPC - Transforming Care With Immunotherapy Combinations in the First-Line Treatment of Advanced or Metastatic Urothelial Carcinoma”, participants will be able to: Discuss the latest evidence with immunotherapy-based combinations in the first-line treatment of locally advanced or metastatic urothelial carcinoma (UC); Outline the practical implications of the data for the management of advanced or metastatic UC in Canadian clinical practice; and Formulate strategies to monitor for, mitigate, and manage dermatologic side effects associated with these combination therapies.
Ready to play
Srikala Sridhar, MD, MSc, FRCPC - Transforming Care With Immunotherapy Combinations in the First-Line Treatment of Advanced or Metastatic Urothelial Carcinoma
No transcript for this episode yet
Similar Episodes
No similar episodes found.